# The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2013, Regulation 6: Amendment of Schedule 4


After paragraph 4 of Part I of Schedule 4 (controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) insert—
“5. A liquid formulation—
(a) containing a botanical extract of cannabis—
(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and
(c) which was approved for marketing by the Medicines and Healthcare products Regulatory Agency on 16th June 2010”.

---
Source: https://www.legislation.gov.uk/nisr/2013/78/regulation/6 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2013/regulation-6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.